Exodus Point Capital Management, LP Organogenesis Holdings Inc. Transaction History

Exodus Point Capital Management, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$2.34 - $4.43 $2.04 Million - $3.86 Million	-870,887 Reduced 87.56%	123,737 $393,000
Q2 2023 Aug 10, 2023	SELL	$1.9 - $4.3 $48,976 - $110,841	-25,777 Reduced 2.53%	994,624 $3.3 Million
Q1 2023 May 11, 2023	BUY	$1.89 - $2.93 $1.6 Million - $2.48 Million	845,648 Added 483.91%	1,020,401 $2.17 Million
Q4 2022 Feb 13, 2023	SELL	$2.48 - $3.43 $14,140 - $19,557	-5,702 Reduced 3.16%	174,753 $470,000
Q3 2022 Nov 10, 2022	BUY	$3.14 - $6.43 $519,230 - $1.06 Million	165,360 Added 1095.46%	180,455 $585,000
Q2 2022 Aug 19, 2022	SELL	$4.74 - $8.15 $425,277 - $731,226	-89,721 Reduced 85.6%	15,095 $74,000
Q1 2022 May 13, 2022	BUY	$6.47 - $9.57 $584,965 - $865,242	90,412 Added 627.69%	104,816 $799,000
Q4 2021 Feb 11, 2022	BUY	$9.02 - $13.5 $129,924 - $194,454	14,404 New	14,404 $133,000
Q3 2021 Nov 15, 2021	SELL	$13.71 - $17.18 $409,408 - $513,029	-29,862 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$14.92 - $23.23 $445,541 - $693,694	29,862 New	29,862 $496,000

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $406M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.